Therapeutic Interventions for COVID-19
Open Access
- 21 June 2023
- book chapter
- Published by IntechOpen
Abstract
SARS-CoV-2, a novel coronavirus, is currently represented a major public health concern. The high transmission rate of this virus increases the mortality rate worldwide. To date, significant efforts and restricted regulations were performed around the world to control this crisis effectively, but unfortunately, there is no specific and successful therapy for COVID-19. Many approaches have been repurposed for SARS-CoV-2 treatment such as antivirals and anti-inflammatories. Furthermore, antibody therapies are one of the main and important approaches of SARS-CoV-2 infection treatment. In recent trials, various immunotherapeutic interventions such as convalescent plasma therapy and monoclonal antibodies, as well as immunomodulatory agents are being proposed. However, the development of a vaccine that provides durable protective immunity will be the most effective therapy for controlling possible epidemics of this virus. The current review summarized all the proposed therapeutic approaches together with information on their safety and efficacy in treating COVID-19, as well as the vaccine candidates. The provided comprehensive information regarding the applied therapeutic strategies against COVID-19 might help the scientific community in any progress toward the treatment of COVID-19 infection.Keywords
This publication has 120 references indexed in Scilit:
- Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell CultureAntimicrobial Agents and Chemotherapy, 2014
- Genetic Variation and Adaptation in Africa: Implications for Human Evolution and DiseaseCold Spring Harbor Perspectives in Biology, 2014
- Activating natural cytotoxicity receptors of natural killer cells in cancer and infectionTrends in Immunology, 2013
- Adaptive immune cells temper initial innate responsesNature Medicine, 2007
- Disappearance of Antibodies to SARS-Associated Coronavirus after RecoveryNew England Journal of Medicine, 2007
- SARS: Systematic Review of Treatment EffectsPLOS Medicine, 2006
- Type I Interferons in Host DefenseImmunity, 2006
- Use of convalescent plasma therapy in SARS patients in Hong KongEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004